 REHOVOT, Israel and HOBOKEN, N.J., Aug. 10, 2022 GLOBE NEWSWIRE -- Kamada Ltd. NASDAQ TASE: KMDA, a vertically integrated global biopharmaceutical company, focused on specialty plasma-derived therapeutics, today announced that it will release financial results for the second quarter and first half ended June 30, 2022, prior to the open of the U.S. financial markets on Wednesday, August 17, 2022. 